You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myeloablative conditioning

Showing 1 - 25 of 1,717
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Melbourne, Victoria, Australia
    Melbourne Health
Jun 19, 2022

Intravenous Busulfan And Fludarabine Myeloablative Conditioning

Completed
  • Acute Myeloid Leukemia
  • +3 more
    • (no location specified)
    Mar 16, 2022

    Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

    Not yet recruiting
    • Lymphoid Leukemia
    • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
    • Treg CD34+ HSPC (Orca-T)
    • Palo Alto, California
      Stanford Cancer Center
    Aug 17, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Fludarabine + Total Marrow Irradiation
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jun 1, 2022

    Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

    Active, not recruiting
    • Sickle Cell Disease
    • Hemoglobinopathies
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Dec 20, 2021

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

    Terminated
    • Acute Myeloid Leukemia
    • +3 more
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Feb 22, 2022

    Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)

    Recruiting
    • Kidney Transplantation
    • TCD601
    • San Francisco, California
    • +4 more
    Oct 28, 2022

    Oral Mucositis Trial in Charlotte (Virgin Coconut Oil)

    Not yet recruiting
    • Oral Mucositis
    • Virgin Coconut Oil
    • Charlotte, North Carolina
      Atrium Health Levine Children's Hospital
    Aug 5, 2022

    Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

    Recruiting
    • Primary T-cell Immunodeficiency Disorders
    • +4 more
    • Immunosuppression Only Conditioning -Closed with amendment L
    • +4 more
    • Bethesda, Maryland
    • +1 more
    Jul 26, 2022

    B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

    Recruiting
    • B-Cell Lymphoid Malignancies
    • +2 more
    • Hematopoietic Stem Cells from HLA-compatible Related
    • Hematopoietic Stem Cells from HLA Unrelated
    • Miami, Florida
      Miami Cancer Institute at Baptist Health of South Florida
    May 5, 2022

    Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)

    Recruiting
    • Sickle Cell Disease
    • αβ+ T-cell depletion with Miltenyi CliniMACS system
    • Chicago, Illinois
      The University of Chicago
    May 13, 2022

    Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

    Active, not recruiting
    • Acute Leukemia
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Stanford (CD8+ Memory T Cell Infusion, Thiotepa, Fludarabine)

    Suspended
    • Acute Myeloid Leukemia
    • +4 more
    • CD8+ Memory T Cell Infusion
    • +5 more
    • Stanford, California
      Stanford Medical Center
    Sep 23, 2021

    Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

    Completed
    • Severe Aplastic Anemia
    • Bone Marrow Failure Syndromes
    • Bone marrow transplant
    • +7 more
    • Baltimore, Maryland
    • +1 more
    Feb 10, 2022

    Kidney Transplantation Trial in United States (TCD601)

    Not yet recruiting
    • Kidney Transplantation
    • TCD601
    • Chicago, Illinois
    • +4 more
    Jun 13, 2022

    Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D)

    Active, not recruiting
    • Cerebral Adrenoleukodystrophy (CALD)
    • Lenti-D
    • Palo Alto, California
    • +7 more
    Mar 22, 2022

    Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival Trial in Canada, United States (drug,

    Completed
    Has Results
    • Myeloablative Conditioning
    • +3 more
    • Aurora, Colorado
    • +8 more
    Nov 23, 2021

    Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jul 6, 2022

    Sickle Cell Disease Trial in United States (Defibrotide)

    Recruiting
    • Sickle Cell Disease
    • Los Angeles, California
    • +3 more
    Mar 29, 2022

    Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

    Completed
    Has Results
    • Metastatic Melanoma
    • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
    • non-myeloablative conditioning chemotherapy
    • Los Angeles, California
      University of California Los Angeles, David Geffen School of Med
    Dec 3, 2021

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +11 more
    • Aldesleukin
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 13, 2022

    B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    Oct 29, 2021

    Single Umbilical Cord Blood Transplantation, Non-myeloablative Conditioning, Acute Lymphocytic Leukemia Trial in Minneapolis

    Completed
    Has Results
    • Single Umbilical Cord Blood Transplantation
    • +6 more
    • Minneapolis, Minnesota
      Novartis Investigative Site
    Dec 9, 2020

    Acute Leukemia, Mielodysplasic Syndrome, Myeloproliferative Tumor Trial (Busulfan Injection)

    Not yet recruiting
    • Acute Leukemia
    • +2 more
    • Busulfan Injection
    • (no location specified)
    Nov 16, 2020